BAROZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 13.238
EU - Europa 6.455
AS - Asia 1.874
SA - Sud America 36
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 6
OC - Oceania 6
Totale 21.634
Nazione #
US - Stati Uniti d'America 13.169
GB - Regno Unito 2.705
IT - Italia 1.258
SE - Svezia 817
CN - Cina 680
DE - Germania 486
UA - Ucraina 371
HK - Hong Kong 346
SG - Singapore 344
TR - Turchia 296
FI - Finlandia 265
FR - Francia 168
BG - Bulgaria 145
IN - India 75
CA - Canada 43
BE - Belgio 39
RU - Federazione Russa 37
CZ - Repubblica Ceca 34
IR - Iran 33
IE - Irlanda 27
BZ - Belize 26
BR - Brasile 22
KR - Corea 20
NL - Olanda 20
ID - Indonesia 19
VN - Vietnam 18
EU - Europa 16
LT - Lituania 13
MY - Malesia 13
JP - Giappone 12
RO - Romania 12
PL - Polonia 10
ES - Italia 8
AU - Australia 6
CL - Cile 6
CH - Svizzera 5
GR - Grecia 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
PT - Portogallo 4
AT - Austria 3
CY - Cipro 3
MD - Moldavia 3
PE - Perù 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BD - Bangladesh 2
CO - Colombia 2
EE - Estonia 2
IL - Israele 2
MA - Marocco 2
MK - Macedonia 2
RS - Serbia 2
A1 - Anonimo 1
EC - Ecuador 1
EG - Egitto 1
GN - Guinea 1
IM - Isola di Man 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
ZA - Sudafrica 1
Totale 21.634
Città #
Southend 2.310
Fairfield 1.976
Woodbridge 1.279
Ashburn 1.051
Chandler 955
Houston 944
Ann Arbor 820
Jacksonville 779
Seattle 729
Wilmington 679
Dearborn 655
Cambridge 588
Nyköping 504
Hong Kong 343
Modena 261
Singapore 214
Beijing 193
Izmir 187
New York 182
San Diego 156
Princeton 149
Sofia 142
Eugene 139
Helsinki 133
Fremont 89
Milan 83
Bremen 71
Des Moines 70
London 57
Rome 55
San Jose 49
Redwood City 48
Boardman 46
Bologna 39
Chicago 38
Brussels 36
Dallas 35
Philadelphia 33
Albuquerque 32
Shanghai 32
Hefei 31
Belize City 26
Dublin 26
Ottawa 25
Las Vegas 23
Nanjing 22
Norwalk 22
Leawood 21
San Mateo 20
Jakarta 19
Tulare 19
Verona 19
Kunming 18
Guangzhou 16
Kilburn 16
Munich 16
Saint Louis 16
Chiswick 15
Toronto 15
Columbus 14
Dong Ket 14
Brno 13
Falls Church 13
Paris 13
Bangalore 12
Jinan 12
Parma 12
Washington 12
Auburn Hills 11
Bari 11
Naples 11
Saint Petersburg 11
Hounslow 10
Nanchang 10
Seongnam 10
Pavia 9
Perugia 9
San Francisco 9
Tokyo 9
Turin 9
Istanbul 8
Reggio Emilia 8
Romainville 8
Ardabil 7
Augusta 7
Castelnuovo Di Porto 7
Florence 7
Los Angeles 7
Prescot 7
Wuhan 7
Acton 6
Amsterdam 6
Andover 6
Atlanta 6
Fuzhou 6
Indiana 6
Islington 6
Mountain View 6
Padova 6
Palermo 6
Totale 16.933
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 281
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 259
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 258
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 241
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 238
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 238
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 235
HHV-6A in syncytial giant-cell hepatitis 230
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 227
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 224
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 221
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 219
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 214
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 211
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 208
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 208
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 206
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 205
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 205
Acute appendicitis in adult neutropenic patients with hematologic malignancies 202
Mucorales-specific T cells in patients with hematologic malignancies 201
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 200
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 199
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 198
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 197
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 197
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 195
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 194
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 193
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 192
B cells and herpesviruses: a model of lymphoproliferation 192
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 191
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 190
Translational challenges of human herpesvirus 6 chromosomal integration. 189
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 189
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 188
Diagnosis of aspergillosis: Role of proteomics 187
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 186
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 184
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 182
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 181
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 181
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 179
Parvoviruses in blood donors and transplant patients, Italy 178
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 177
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 177
How I treat HHV8/KSHV-related diseases in posttransplant patients. 176
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 174
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 173
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 170
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 168
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 167
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 167
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 166
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 166
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 166
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 166
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 165
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 160
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 159
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 159
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 159
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 158
Human herpesvirus-6 genome in acute lymphoblastic leukemia: Evidence against an etiologic relationship 157
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 156
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 156
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 153
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 151
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 151
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 151
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 150
Expression of cell-homologous genes of human herpesvirus-8 in human immunodeficiency virus-negative lymphoproliferative diseases 150
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 148
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 148
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 147
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 146
Human herpesvirus 6 infection in normal human brain tissue 144
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 144
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 144
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 144
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 143
CHARACTERIZATION OF HUMAN HERPESVIRUS-6 GENOMES FROM CASES OF LATENT INFECTION IN HUMAN LYMPHOMAS AND IMMUNE DISORDERS 142
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 142
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 140
KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney 140
Skin cancers after organ transplantation 140
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 138
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 137
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 137
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 137
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 136
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 135
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 135
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 135
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 135
Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation 135
Spontaneous loss of Ph chromosome with maintenance of clonal hemopoiesis in an untreated patient with myeloproliferative disease and a long survival. 134
FREQUENT DETECTION OF HUMAN HERPESVIRUS-6 SEQUENCES BY POLYMERASE CHAIN-REACTION IN PARAFFIN-EMBEDDED LYMPH-NODES FROM PATIENTS WITH ANGIOIMMUNOBLASTIC LYMPHADENOPATHY AND ANGIOIMMUNOBLASTIC LYMPHADENOPATHY-LIKE LYMPHOMA 132
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 132
P53 gene mutations in chronic myelogenous leukemia medullary and extramedullary blast crisis 132
Totale 17.543
Categoria #
all - tutte 89.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.480 0 0 0 318 563 701 1.058 751 452 176 229 232
2020/20213.551 300 178 267 441 431 228 242 429 168 450 223 194
2021/20222.760 76 381 381 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/2025488 248 71 101 68 0 0 0 0 0 0 0 0
Totale 21.916